Authors: Deplanque, G Ceraline, J Mah-Becherel, MCM Cazenave, JP Bergerat, JP Klein-Soyer, C

Citation: G. Deplanque et al., Caffeine and the G2/M block override: A concept resulting from a misleading cell kinetic delay, independent of functional p53, INT J CANC, 94(3), 2001, pp. 363-369

Authors: Deplanque, G Harris, AL

Citation: G. Deplanque et Al. Harris, Anti-angiogenic agents: clinical trial design and therapies in development, EUR J CANC, 36(13), 2000, pp. 1713-1724

Authors: Kurtz, JE Deplanque, G Borel, C Mathelin, C Prevost, G Poulin, G Barats, JC Bergerat, JP Chapelle-Marcillac, I Bardonnet, M Dufour, P

Citation: Je. Kurtz et al., Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer, ANN ONCOL, 11(2), 2000, pp. 229-230

Authors: Deplanque, G Vincent, F Mah-Becherel, MCM Cazenave, JP Bergerat, JP Klein-Soyer, C

Citation: G. Deplanque et al., Caffeine does not cause override of the G2/M block induced by UVc or gammaradiation in normal human skin fibroblasts, BR J CANC, 83(3), 2000, pp. 346-353

Authors: Kurtz, JE Deplanque, G Duclos, B Giron, C Lioure, B Limacher, JM Herbrecht, R Laplace, A Bergerat, JP Dufour, P

Citation: Je. Kurtz et al., A phase I/II study of dose-escalated ifosfamide plus carboplatin combination for advanced ovarian carcinoma, ONKOLOGIE, 22(3), 1999, pp. 212-215

Authors: Vincent, F Deplanque, G Ceraline, J Duclos, B Bergerat, JP

Citation: F. Vincent et al., p53-independent regulation of cyclin B1 in normal human fibroblasts duringUV-induced G2-arrest, BIO CELL, 91(9), 1999, pp. 665-674